Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000070858-25-000227·BANK OF AMERICA CORP /DE/
Schedule 13G ownership disclosure
Ventyx Biosciences Inc
Common Stock · CUSIP: 92332V107
Event date: 2025-03-31
- Filing-level shares
- 1,016,649.00
- Percent of class
- 1.4%
- BANK OF AMERICA CORP /DE/
Shares: 1,016,649.00 · Class: 1.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000070858-25-000227
- Form type
- SCHEDULE 13G/A
- Filer
- BANK OF AMERICA CORP /DE/
- CIK
- CIK 70858
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership